General Atlantic LLC
- SEC CIK
- 0001017645
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 13, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 16
- +1 vs. Q2 2025
- Portfolio value
- $3.33B
- −$298.7M (−8.2%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 2,474,859 | $3.71M | 0.1% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 1,297,530 | $5.18M | 0.2% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 3,782,339 | $7.53M | 0.2% | −43,613−1.1% | Reduced | History |
| RSKDRiskified Ltd. | SHS CL A | 5,324,998 | $24.9M | 0.7% | 00.0% | Unchanged | History |
| EWCZEuropean Wax Center, Inc. | CLASS A COM | 13,110,492 | $52.3M | 1.6% | 00.0% | Unchanged | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 1,500,000 | $52.9M | 1.6% | 00.0% | Unchanged | History |
| BULLWebull Corp | ORD SHS | 7,198,867 | $106.5M | 3.2% | +50,816+0.7% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 2,474,428 | $115.6M | 3.5% | +2,474,428 | New | History |
| PHVSPharvaris N.V. | COM | 8,031,252 | $200.4M | 6.0% | +500,000+6.6% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,681,818 | $234.8M | 7.0% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 5,733,989 | $272.2M | 8.2% | 00.0% | Unchanged | History |
| ALKTAlkami Technology, Inc. | Stock | 11,991,480 | $297.9M | 8.9% | +2,346,162+24.3% | Added | History |
| CHYMChime Financial, Inc. | COM SHS CL A | 19,208,760 | $387.4M | 11.6% | 00.0% | Unchanged | History |
| ALHCAlignment Healthcare, Inc. | COM | 24,287,227 | $423.8M | 12.7% | −19,706,096−44.8% | Reduced | History |
| XPXP Inc. | CL A | 25,517,733 | $479.5M | 14.4% | 00.0% | Unchanged | History |
| DLOdLocal Ltd | CLASS A COM | 46,656,695 | $666.3M | 20.0% | −17,250,000−27.0% | Reduced | History |